CTRI/2019/12/022302
Completed
未知
A clinical study to evaluate the efficacy of Aparajit Avaleha in the management of Vataja Kasa in children
Department of Kaumarbhritya0 sites30 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: J069- Acute upper respiratory infection,unspecified
- Sponsor
- Department of Kaumarbhritya
- Enrollment
- 30
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Patients of Vataja Kasa with symptoms Parshavshool, Shirashool, Urashool, Sawarbheda, Shuska Mukha and Gala as a major symptoms.
- •2\.Acute Cough of less than 7 days.
- •3\.Newly diagnosed cases of Vataja Kasa.
Exclusion Criteria
- •1\.Patients below age of 6 years and above age of 12 years.
- •2\.Patients with chronic debilitating disease or disorders.
- •3\.All types of Kasa except Vataja Kasa Lakshana will be excluded.
- •4\.Conditions like Pneumonia, Juvenile Diabetes Mellitus, Tuberculosis, Bronchiolitis, Asthma \< Chronic Productive Cough, Whooping Cough, Sinusitis, Tonsillitis should be excluded.
- •Cough with High Grade Fever.
- •5\.If Cough aggravates during treatment then it will be excluded.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 2
Effect of arka patra sweda in katigrhaHealth Condition 1: null- katigrahaCTRI/2017/08/009420Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital
Not yet recruiting
Phase 2
Treatment of Diabetic Peripheral Neuropathy through ayurvedic line of management.Health Condition 1: E114- Type 2 diabetes mellitus with neurological complicationsCTRI/2023/10/058822Dr H S Harshitha
Not yet recruiting
Phase 3
Effect Of Aartavpravartak Yog And Hingwaadi Tail (Uttarbasti and Yoni Varti) In The Management Of Oligomenorrhoea/HypomenorrhoeaCTRI/2024/05/066625Rajiv Gandhi Government Post Graduate Ayurvedic College and Hospital
Not yet recruiting
Phase 3
Clinical study of Indian gooseberry seed powder (Emblica officinalis)in the management of leucorrhoeaCTRI/2023/09/057191Farida Parbin
Not yet recruiting
Phase 2
Effect of the test product in reducing dark spotsCTRI/2024/03/064874Hindustan Unilever Limited